NASDAQ$MDRX
Veradigm Inc · Q4 2019 earnings
Q4 2019 earnings · · Investor relations
Briefing
Allscripts' Q4 2019 results were announced, revealing increased bookings and revenue, but a GAAP net loss was reported.
Allscripts reported a 6% year-over-year increase in bookings, reaching $312 million in Q4 2019. GAAP revenue increased to $451 million, while a GAAP net loss of $19 million was reported, contrasting with the previous year's net income. The company also extended its managed services agreement with Northwell Health and saw its contract revenue backlog rise to $4.4 billion.
- Allscripts Q4 2019 bookings increased by 6% year-over-year, reaching $312 million.
- The company extended its Allscripts Managed Services Agreement with Northwell Health through 2026.
- Contract revenue backlog increased by $500 million, totaling $4.4 billion at the end of Q4.
- Rick Poulton was named President and Chief Financial Officer, effective March 3, 2020.
Headline financials
Revenue & EPS history
Allscripts · Revenue · Quarterly
$414M
Revenue by segment
Allscripts · $451M total across 2 segments · Q4 2019
- Software delivery, support...$282M-2.6%62.4%
- Client services$169M+10.6%37.6%
Forward guidance
Allscripts provided financial outlook for the full year 2020 and first quarter 2020.
Tailwinds
- Full year 2020 bookings between $900 million and $1,000 million
- Full year 2020 revenue between $1,750 million and $1,850 million
- Full year 2020 non-GAAP earnings per share between $0.70 and $0.75
- First quarter 2020 bookings between $175 million and $200 million
- First quarter 2020 revenue between $420 million and $430 million
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2019
-0.3%
Avg return
Earnings day
-0.5%
Avg return
5 days after
-0.9%
Avg return
30 days after
38%
20 / 52 earnings
Positive
+21.1%
Q2 2020
Best reaction
-17.9%
Q3 2018
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2022 | -0.2% | -0.8% | -1.3% | |
| Q3 2022 | +9.9% | +18.4% | +33.7% | |
| Q2 2022 | +11.1% | +9.6% | +5.4% | |
| Q1 2022 | +3.0% | +1.2% | -7.9% | |
| Q4 2021 | -2.1% | -0.2% | +9.4% | |
| Q3 2021 | +7.6% | +7.3% | +19.2% | |
| Q2 2021 | +1.7% | -0.3% | -11.1% | |
| Q1 2021 | +1.4% | +2.6% | +2.8% | |
| Q4 2020 | -4.8% | -6.4% | -5.6% | |
| Q2 2020 | +21.1% | +18.3% | +21.0% | |
| Q1 2020 | -7.2% | -14.8% | -10.1% | |
| Q4 2019 | -3.2% | +1.3% | -11.0% | |
| Q3 2019 | -4.1% | -3.5% | -13.5% | |
| Q2 2019 | -5.1% | -11.4% | -9.4% | |
| Q1 2019 | -0.3% | +1.4% | +3.5% | |
| Q4 2018 | -8.7% | -9.4% | -17.1% | |
| Q3 2018 | -17.9% | -10.7% | -15.2% | |
| Q2 2018 | -3.5% | -1.1% | +5.0% | |
| Q1 2018 | -2.3% | +0.0% | -5.9% | |
| Q4 2017 | +0.5% | +2.3% | -11.5% | |
| Q3 2017 | -3.5% | -2.2% | +10.5% | |
| Q2 2017 | +13.5% | +5.9% | +13.3% | |
| Q1 2017 | -1.4% | -2.1% | -5.5% | |
| Q4 2016 | +1.1% | -1.8% | -3.3% | |
| Q3 2016 | -9.8% | -11.5% | -9.6% | |
| Q2 2016 | -2.5% | -4.3% | -9.7% | |
| Q1 2016 | +3.5% | — | — | |
| Q4 2015 | +0.5% | — | — | |
| Q3 2015 | +4.5% | — | — | |
| Q2 2015 | +0.8% | — | — | |
| Q1 2015 | -1.3% | — | — | |
| Q4 2014 | +2.9% | — | — | |
| Q3 2014 | -16.8% | — | — | |
| Q2 2014 | -2.6% | — | — | |
| Q1 2014 | +1.6% | — | — | |
| Q4 2013 | +1.6% | — | — | |
| Q3 2013 | +1.5% | — | — | |
| Q2 2013 | -3.4% | — | — | |
| Q1 2013 | -0.9% | — | — | |
| Q4 2012 | -1.1% | — | — | |
| Q3 2012 | +0.0% | — | — | |
| Q2 2012 | +19.4% | — | — | |
| Q1 2012 | -0.0% | — | — | |
| Q4 2011 | -1.9% | — | — | |
| Q3 2011 | -2.8% | — | — | |
| Q2 2011 | -2.6% | — | — | |
| Q3 2010 | -0.2% | — | — | |
| Q2 2010 | -2.5% | — | — | |
| Q4 2009 | -2.5% | — | — | |
| Q1 2011 | +1.0% | — | — | |
| Q4 2010 | -3.4% | — | — | |
| Q1 2010 | -3.4% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro